These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 26493254)

  • 21. Directional Atherectomy Followed by a Paclitaxel-Coated Balloon to Inhibit Restenosis and Maintain Vessel Patency: Twelve-Month Results of the DEFINITIVE AR Study.
    Zeller T; Langhoff R; Rocha-Singh KJ; Jaff MR; Blessing E; Amann-Vesti B; Krzanowski M; Peeters P; Scheinert D; Torsello G; Sixt S; Tepe G;
    Circ Cardiovasc Interv; 2017 Sep; 10(9):e004848. PubMed ID: 28916599
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vasculitis resulting from a superficial femoral artery angioplasty with a paclitaxel-eluting balloon.
    Thomas SD; McDonald RR; Varcoe RL
    J Vasc Surg; 2014 Feb; 59(2):520-3. PubMed ID: 23642919
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effectiveness of the paclitaxel-coated Luminor® balloon catheter versus an uncoated balloon catheter in superficial femoral and popliteal arteries in preventing vessel restenosis or reocclusion: study protocol for a randomized controlled trial.
    Teichgräber U; Aschenbach R; Scheinert D; Zeller T; Brechtel K; Thieme M; Blessing E; Treitl M; Lichtenberg M; von Flotow P; Vogel B; Werk M; Riambau V; Wienke A; Lehmann T; Sixt S
    Trials; 2016 Oct; 17(1):528. PubMed ID: 27793175
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical Randomized Trial Evaluating Novel, Microcrystalline, and Biocompatible Polymer Paclitaxel-Coated Balloon for the Treatment of Femoropopliteal Occlusive Disease: The BIOPAC Trial.
    Buszman PP; Nowakowski P; Milewski K; Orlik B; Żurakowski A; Ludyga T; Polczyk F; Dębiński M; Jelonek M; Kachel M; Gąsior M; Granada JF; Kiesz RS; Buszman PE
    JACC Cardiovasc Interv; 2018 Dec; 11(23):2436-2438. PubMed ID: 30522679
    [No Abstract]   [Full Text] [Related]  

  • 25. 1-Year Results of Paclitaxel-Coated Balloons for Long Femoropopliteal Artery Disease: Evidence From the SFA-Long Study.
    Micari A; Vadalà G; Castriota F; Liso A; Grattoni C; Russo P; Marchese A; Pantaleo P; Roscitano G; Cesana BM; Cremonesi A
    JACC Cardiovasc Interv; 2016 May; 9(9):950-6. PubMed ID: 27151609
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Commentary: Role of Self-Expanding Stents in Infrapopliteal Artery Disease.
    Jafferani A; Dieter RS
    J Endovasc Ther; 2015 Oct; 22(5):698-700. PubMed ID: 26392474
    [No Abstract]   [Full Text] [Related]  

  • 27. Treating complex femoropopliteal lesions.
    van der Vijver-Coppen RJ; 't Mannetje YW; Menting TP; Lardenoije JW; Reijnen MP
    J Cardiovasc Surg (Torino); 2018 Apr; 59(2):158-163. PubMed ID: 29327573
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Paclitaxel-Eluting Balloon vs Standard Angioplasty to Reduce Restenosis in Diabetic Patients With In-Stent Restenosis of the Superficial Femoral and Proximal Popliteal Arteries: Three-Year Results of the DEBATE-ISR Study.
    Grotti S; Liistro F; Angioli P; Ducci K; Falsini G; Porto I; Ricci L; Ventoruzzo G; Turini F; Bellandi G; Bolognese L
    J Endovasc Ther; 2016 Feb; 23(1):52-7. PubMed ID: 26511896
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Drug-eluting balloon catheters for lower limb peripheral arterial disease: the evidence to date.
    Barkat M; Torella F; Antoniou GA
    Vasc Health Risk Manag; 2016; 12():199-208. PubMed ID: 27274265
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Commentary: intravascular ultrasound for femoropopliteal stenting: can it predict outcomes with current-generation stents?
    Foley TR; Armstrong EJ
    J Endovasc Ther; 2015 Jun; 22(3):350-1. PubMed ID: 25904483
    [No Abstract]   [Full Text] [Related]  

  • 31. Angioplasty with drug coated balloons for the treatment of infrainguinal peripheral artery disease.
    Werner M
    Vasa; 2016 Sep; 45(5):365-72. PubMed ID: 27351416
    [TBL] [Abstract][Full Text] [Related]  

  • 32. First-in-human experience with the sirolimus-coated balloon in ischemic peripheral arterial disease and occlusion of the common femoral artery.
    Donas KP; Bakr NA; Paripovic M
    Vascular; 2021 Feb; 29(1):150-151. PubMed ID: 32646289
    [No Abstract]   [Full Text] [Related]  

  • 33. Paclitaxel-Coated Balloon for Femoropopliteal Artery Disease.
    Mehrotra S; Paramasivam G; Mishra S
    Curr Cardiol Rep; 2017 Feb; 19(2):10. PubMed ID: 28185166
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 2-year results of paclitaxel-eluting balloons for femoropopliteal artery disease: evidence from a multicenter registry.
    Micari A; Cioppa A; Vadalà G; Castriota F; Liso A; Marchese A; Grattoni C; Pantaleo P; Cremonesi A; Rubino P; Biamino G
    JACC Cardiovasc Interv; 2013 Mar; 6(3):282-9. PubMed ID: 23517840
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Commentary: is the drug-eluting balloon the answer to the epidemic of restenosis?
    Owens CD
    J Endovasc Ther; 2014 Feb; 21(1):22-4. PubMed ID: 24502480
    [No Abstract]   [Full Text] [Related]  

  • 36. A Pilot Study of Femoropopliteal Artery Revascularisation with a Low Dose Paclitaxel Coated Balloon: Is Predilatation Necessary?
    Schroeder H; Meyer DR; Lux B; Ruecker F; Martorana M; Miller LE; Duda S
    Eur J Vasc Endovasc Surg; 2017 Sep; 54(3):348-355. PubMed ID: 28778456
    [TBL] [Abstract][Full Text] [Related]  

  • 37. ISAR-PEBIS (Paclitaxel-Eluting Balloon Versus Conventional Balloon Angioplasty for In-Stent Restenosis of Superficial Femoral Artery): A Randomized Trial.
    Ott I; Cassese S; Groha P; Steppich B; Voll F; Hadamitzky M; Ibrahim T; Kufner S; Dewitz K; Wittmann T; Kasel AM; Laugwitz KL; Schunkert H; Kastrati A; Fusaro M
    J Am Heart Assoc; 2017 Jul; 6(7):. PubMed ID: 28743787
    [TBL] [Abstract][Full Text] [Related]  

  • 38. How should I treat a restenosis after superficial femoral artery stenting?
    Fusaro M; Cassese S; Byrne RA
    EuroIntervention; 2013 Mar; 8(11):1342-5. PubMed ID: 23538161
    [No Abstract]   [Full Text] [Related]  

  • 39. In-stent restenosis management: the best is yet to come.
    van den Berg JC
    J Cardiovasc Surg (Torino); 2017 Aug; 58(4):508-517. PubMed ID: 28322039
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Iloprost treatment on top of infrapopliteal angioplasty accelerates wound healing in critical leg ischemia.
    K Ay N; Inan B
    Vascular; 2020 Feb; 28(1):74-80. PubMed ID: 31357910
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.